// App-Quantinova.ai

: Prediction of Initial Risk Group, B/T Subtype, and ETV6-RUNX1 Translocation in Pediatric Acute Lymphoblastic Leukemia By Deep Convolutional Neural Network Analysis of Giemsa-Stained Whole Slide Images

Researchers

Presenter

  • Gil Shamai

Principal Investigators

  • Ran Schley

  • Yoav Binenbaum

  • Ron Kimmel

  • Ronit Elhasid

Medical Centers

  • Dana Farber Cancer Institute, Boston

  • TECHNION - Israel Institute of Technology, Haifa, Israel

  • Pediatric Hemato-Oncology Department, Sourasky Medical Center, Tel Aviv, Israel

Locations

  • United States

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • ETV6-RUNX1

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved